Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT05377333
Eligibility Criteria:
Inclusion Criteria:
* Participants with type 2 diabetes (T2D) at least 6 months before screening
* Participants treated for T2D with diet and exercise, with or without metformin
* Have a glycated hemoglobin A1c (HbA1c) value of ≥ 7.5% and ≤10.5%
* Have had a stable body weight for 3 months and body mass index (BMI) of 27.0 to 45.0 kilograms per meter squared (kg/m²)
* Male participants who agree to use effective methods of contraception and female participants not of childbearing potential
Exclusion Criteria:
* Have a history of or current cardiovascular, respiratory, hepatic, renal, GI, endocrine (apart from T2D), hematological, or neurological disorders capable of altering the absorption, metabolism, or elimination of drugs
* Have type 1 diabetes mellitus or latent autoimmune diabetes in adults or maturity-onset diabetes of the young
* Have a history of proliferative diabetic retinopathy, diabetic maculopathy, or severe non-proliferative diabetic retinopathy
* Have known allergies to GLP-1 receptor agonists
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT05377333
Study Brief:
Protocol Section:
NCT05377333